COVID-19 Patients with Coinfection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus
In Shenzhen, China (Jan. 2020), a patient with a travel history to Wuhan was admitted to the hospital with the clinical presentation of COVID-19. The SARS-CoV-2 RNA test was persistently negative, but the plasma anti-SARS-CoV-2 antibody was positive.
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Mortality in Secondary COVID-19 Infection in Wuhan, China
Co-Infections in SARS-CoV-2 Patients in Northern California, United States
Time until Onset of Secondary SARS-CoV-2 Infection in COVID-19 Patients in Wuhan, China
COVID-19 Patients with Coinfection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus
COVID-19 Patients with Coinfection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus
Review: HIV/SARSāCoVā2 coinfection: a global perspective